Compliance with herpes zoster vaccination in young and adult individuals in two regions of Italy
Open Access
- 12 June 2010
- journal article
- Published by Springer Nature in BMC Public Health
- Vol. 10 (1) , 333
- https://doi.org/10.1186/1471-2458-10-333
Abstract
Background The purpose of this work was to explore the knowledge and acceptance of Varicella Zoster Virus (VZV)-Herpes Zoster (HZ) vaccination in the general Italian population, where the HZ vaccine has not yet been distributed, using a prevalence study of subjects from two regions in Italy. Methods A group of 3,173 individuals were interviewed using a questionnaire. The youngest age group (≤ 20 year) was composed of students interviewed at university. The middle age group (21-40 years) and the older age group (≥ 41 years) were interviewed by general practitioners in their office. Results In both regions, the majority of subjects had been infected with varicella, and only 165 (5.2%) subjects reported receiving the VZV vaccination. Regarding HZ, 2,749 (86.6%) individuals stated that they knew of the virus and 2,233 (70%) were willing to be vaccinated against HZ. The majority of people willing to be vaccinated were in the middle and older age groups (36.6% and 44.7%, respectively). Conclusion Compliance versus vaccination results were satisfactory and probably, with the upcoming availability of the HZ vaccine in Italy, adults will be favourably disposed towards vaccination.Keywords
This publication has 37 references indexed in Scilit:
- A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UKCost Effectiveness and Resource Allocation, 2010
- Public Awareness and Knowledge of Herpes Zoster: Results of a Global SurveyGerontology, 2009
- Varicella zoster vaccinesDermatologic Therapy, 2009
- The Epidemiological, Clinical, and Pathological Rationale for the Herpes Zoster VaccineThe Journal of Infectious Diseases, 2008
- Preventing Herpes Zoster through VaccinationOphthalmology, 2008
- Safety and Immunogenicity Profile of the Concomitant Administration of ZOSTAVAX and Inactivated Influenza Vaccine in Adults Aged 50 and OlderJournal of the American Geriatrics Society, 2007
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsNew England Journal of Medicine, 2005
- Epidemiology of severe varicella?zoster virus infection in SpainVaccine, 2004
- Epidemiology of varicella-zoster virus in England and WalesJournal of Medical Virology, 2003
- Population-Based Study of Herpes Zoster and Its SequelaeMedicine, 1982